Q3 2021 Holdings
Filed 2021-11-15 | 88 holdings | $491.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $172.8M | 4,928,756 | 35.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $82.9M | 1,768,909 | 16.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $74.8M | 1,012,079 | 15.2% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $38.0M | 3,170,872 | 7.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $35.7M | 1,000,000 | 7.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $27.1M | 170,000 | 5.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $27.0M | 1,500,000 | 5.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $19.6M | 1,611,623 | 4.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $8.7M | 100,000 | 1.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.6M | 392,167 | 0.5% |
| Erasca Inc(ERAS) | COM | 29479A108 | $216.8K | 10,505,550 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $188.8K | 2,842,297 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $109.5K | 4,720,495 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $86.5K | 3,144,700 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $84.7K | 3,073,485 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $78.8K | 5,364,850 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $68.0K | 3,102,199 | 0.0% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $58.5K | 2,252,626 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $56.0K | 3,370,914 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $53.5K | 1,815,546 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $53.3K | 2,162,115 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $48.8K | 3,899,185 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $43.8K | 1,848,024 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $42.0K | 2,030,691 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $34.8K | 2,326,660 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $33.1K | 2,486,386 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $32.7K | 709,224 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $32.5K | 1,278,276 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $31.1K | 1,444,831 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $30.5K | 925,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $29.0K | 968,550 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $28.7K | 1,727,273 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $27.6K | 950,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $25.2K | 4,807,557 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $23.0K | 350,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $21.2K | 120,000 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $21.0K | 322,240 | 0.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $20.2K | 2,273,221 | 0.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $18.9K | 1,024,161 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $18.2K | 1,069,932 | 0.0% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $17.2K | 2,226,128 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $16.3K | 1,215,847 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $15.4K | 150,000 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $15.1K | 1,983,165 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $14.5K | 200,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $14.3K | 500,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $13.4K | 600,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $13.1K | 608,123 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $13.1K | 950,000 | 0.0% |
| Icosavax Inc | COM | 45114M109 | $12.2K | 426,393 | 0.0% |